Search Results - Virginia Laspidea
- Showing 1 - 4 results of 4
-
1
1097 New immunomodulatory roles of NONO pathway during glioma virotherapy by Hong Jiang, Frederick Lang, Juan Fueyo, Dong Ho Shin, Marta Alonso, Virginia Laspidea, Xuejun Fan, Andrew G Gillard, Jiasen He, Andres Lopez-Rivas, Akhila Parthasarathy, Candelaria Gomez Manzano
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
2
Combination of locoregional radiotherapy with a TIM-3 aptamer improves survival in diffuse midline glioma models by Iker Ausejo-Mauleon, Naiara Martinez-Velez, Andrea Lacalle, Daniel de la Nava, Javier Cebollero, Helena Villanueva, Noelia Casares, Javier Marco-Sanz, Virginia Laspidea, Oren Becher, Ana Patiño-García, Sara Labiano, Fernando Pastor, Marta M. Alonso
Published in JCI Insight (2024-09-01)Get full text
Article -
3
CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models by Hong Jiang, Sandra Hervás-Stubbs, Sara Labiano, Candelaria Gomez-Manzano, Juan Fueyo, Marta Alonso, Zhihong Chen, Montserrat Puigdelloses, Marc Garcia-Moure, Virginia Laspidea, Marisol Gonzalez-Huarriz, Marta Zalacain, Lucia Marrodan, Naiara Martinez-Velez, Daniel De la Nava, Iker Ausejo, Guillermo Herrador, Dolores Hambardzumyan, Ana Patino Garcia, Jaime Gállego Pérez-Larraya
Published in Journal for ImmunoTherapy of Cancer (2021-07-01)Get full text
Article -
4
Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas by Virginia Laspidea, Montserrat Puigdelloses, Sara Labiano, Lucía Marrodán, Marc Garcia-Moure, Marta Zalacain, Marisol Gonzalez-Huarriz, Naiara Martínez-Vélez, Iker Ausejo-Mauleon, Daniel de la Nava, Guillermo Herrador-Cañete, Javier Marco-Sanz, Elisabeth Guruceaga, Carlos E. de Andrea, María Villalba, Oren Becher, Massimo Squatrito, Verónica Matía, Jaime Gállego Pérez-Larraya, Ana Patiño-García, Sumit Gupta, Candelaria Gomez-Manzano, Juan Fueyo, Marta M. Alonso
Published in JCI Insight (2022-04-01)Get full text
Article
